{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:59:02Z","timestamp":1760975942799},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.2515\/therapie\/2015039","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T06:35:11Z","timestamp":1438065311000},"page":"539-540","source":"Crossref","is-referenced-by-count":2,"title":["Acouph\u00e8nes chez un patient trait\u00e9 par bl\u00e9omycine pour un sarcome de Kaposi"],"prefix":"10.1016","volume":"70","author":[{"given":"B\u00e9reng\u00e8re","family":"Laschinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Arnault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2015039_bb0890","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit bl\u00e9omycine Bellon 15mg. Mise \u00e0 jour 26 septembre 2013 http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0229435.htm Consult\u00e9 le 15 juin 2015 (1 page)"},{"key":"10.2515\/therapie\/2015039_bb0895","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit bl\u00e9omycine Teva 15 000 UI. Mise \u00e0 jour 14 mai 2013 http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0222812.htm Consult\u00e9 le 15 juin 2015 (1 page)"},{"issue":"3","key":"10.2515\/therapie\/2015039_bb0900","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00002018-199614030-00006","article-title":"Drug-induced tinnitus and other hearing disorders","volume":"14","author":"Seligmann","year":"1996","journal-title":"Drug Saf"},{"issue":"5-6","key":"10.2515\/therapie\/2015039_bb0905","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00206097309071648","article-title":"Ototoxicity: a clinical review","volume":"12","author":"Ballantyne","year":"1973","journal-title":"Int J Audiol"},{"issue":"8","key":"10.2515\/therapie\/2015039_bb0910","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1989.7.8.1099","article-title":"Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin","volume":"7","author":"Stoter","year":"1989","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.2515\/therapie\/2015039_bb0915","first-page":"391","article-title":"Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin","volume":"39","author":"Hansen","year":"1992","journal-title":"Dan Med Bull"},{"issue":"8","key":"10.2515\/therapie\/2015039_bb0920","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"issue":"4","key":"10.2515\/therapie\/2015039_bb0925","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1345\/aph.18288","article-title":"Ototoxicity associated with vinblastine","volume":"33","author":"Moss","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.2515\/therapie\/2015039_bb0930","unstructured":"Base nationale de pharmacovigilance. Consult\u00e9e le 22 octobre 2014."},{"issue":"2","key":"10.2515\/therapie\/2015039_bb0935","first-page":"111","article-title":"Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"issue":"4","key":"10.2515\/therapie\/2015039_bb0940","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/00016487309139733","article-title":"Bleomycin therapy and ototoxicity","volume":"75","author":"Dal","year":"1973","journal-title":"Acta Otolaryngol"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571631099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571631099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T12:03:25Z","timestamp":1554293005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571631099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S004059571631099X"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015039","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}